News
This was the stock's fifth consecutive day of gains.
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 ...
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains
Shares of Boston Scientific Corp. BSX rose 1.72% to $104.12 Tuesday, on what proved to be an all-around favorable trading ...
13h
Zacks Investment Research on MSNBoston Scientific (BSX) Surpasses Market Returns: Some Facts Worth KnowingIn the latest trading session, Boston Scientific (BSX) closed at $106.53, marking a +1.86% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.52%. At ...
With data as of June 16, 2025, we examine if Boston Scientific Corporation(BSX) is consistently building momentum based on ...
Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to buy. On June 10, the company announced that it is ...
Buying $100 In BSX: If an investor had bought $100 of BSX stock 10 years ago, it would be worth $564.45 today based on a price of $99.23 for BSX at the time of writing.
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Boston Scientific has put its 24-acre Minnetonka, Minnesota, campus up for sale as it continues to expand in nearby Maple Grove.
Outside Minneapolis, Boston Scientific has put one of its locations up for sale while expanding another nearby, according to ...
Boston Scientific (NYSE:BSX) recently entered into a significant agreement with Bittium Biosignals Ltd. to supply ECG devices, valued between USD 30 to 45 million, which strengthens their cardiac ...
Boston Scientific agreed to pay Johnson & Johnson $600 million in connection with Johnson & Johnson’s botched acquisition of Guidant, a medical device company, in 2004.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results